• Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
  

PubMed=9469433; DOI=10.4049/jimmunol.160.4.1750
Valmori D., Fonteneau J.-F., Lizana C.M., Gervois-Segain N., Lienard D., Rimoldi D., Jongeneel C.V., Jotereau F., Cerottini J.-C., Romero P.
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.
J. Immunol. 160:1750-1758(1998)

PubMed=20862285; DOI=10.1371/journal.pone.0012773; PMCID=PMC2940856
Caballero O.L., Zhao Q., Rimoldi D., Stevenson B.J., Svobodova S., Devalle S., Rohrig U.F., Pagotto A., Michielin O., Speiser D.E., Wolchok J.D., Liu C.-L., Pejovic T., Odunsi K., Brasseur F., van den Eynde B.J., Old L.J., Lu X., Cebon J.S., Strausberg R.L., Simpson A.J.G.
Frequent MAGE mutations in human melanoma.
PLoS ONE 5:e12773.1-e12773.7(2010)

PubMed=21494657; DOI=10.1371/journal.pone.0018369; PMCID=PMC3072964
Valsesia A., Rimoldi D., Martinet D., Ibberson M., Benaglio P., Quadroni M., Waridel P., Gaillard M., Pidoux M., Rapin B., Rivolta C., Xenarios I., Simpson A.J.G., Antonarakis S.E., Beckmann J.S., Jongeneel C.V., Iseli C., Stevenson B.J.
Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma.
PLoS ONE 6:e18369.1-e18369.12(2011)

PubMed=22197931; DOI=10.1038/ng.1026
Nikolaev S.I., Rimoldi D., Iseli C., Valsesia A., Robyr D., Gehrig C., Harshman K., Guipponi M., Bukach O.V., Zoete V., Michielin O., Muehlethaler K., Speiser D.E., Beckmann J.S., Xenarios I., Halazonetis T.D., Jongeneel C.V., Stevenson B.J., Antonarakis S.E.
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.
Nat. Genet. 44:133-139(2011)